Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Bioextrax AB (publ) (85X0.F)

Compare
0.1995
-0.0115
(-5.45%)
As of 9:59:01 AM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,203
515
2,056
395
276
Cost of Revenue
1,456
1,430
1,338
1,345
1,033
Gross Profit
-253
-915
718
-950
-757
Operating Expense
19,519
16,624
22,317
17,717
9,772
Operating Income
-19,772
-17,539
-21,599
-18,667
-10,529
Net Non Operating Interest Income Expense
127
201
92
--
-3
Pretax Income
-19,645
-17,338
-21,507
-18,667
-10,532
Net Income Common Stockholders
-19,645
-17,338
-21,507
-18,667
-10,532
Diluted NI Available to Com Stockholders
-19,645
-17,338
-21,507
-18,667
-10,532
Basic EPS
-0.52
--
-0.81
-1.09
-0.78
Diluted EPS
-0.52
--
-0.81
-1.09
-0.78
Basic Average Shares
33,333.2820
--
26,520.2460
17,048.7040
13,522.1220
Diluted Average Shares
33,333.2820
--
26,520.2460
17,048.7040
13,522.1220
Total Operating Income as Reported
-19,772
-17,539
-21,599
-18,667
-10,529
Total Expenses
20,975
18,054
23,655
19,062
10,805
Net Income from Continuing & Discontinued Operation
-19,645
-17,338
-21,507
-18,667
-10,532
Normalized Income
-19,645
-17,338
-21,507
-18,667
-10,532
Interest Income
130
203
92
--
--
Interest Expense
3
2
--
--
3
Net Interest Income
127
201
92
--
-3
EBIT
-19,642
-17,336
-21,507
-18,667
-10,529
EBITDA
-18,456
-16,177
-20,646
-18,190
-10,179
Reconciled Cost of Revenue
1,456
1,430
1,338
1,345
1,033
Reconciled Depreciation
1,186
1,159
861
477
350
Net Income from Continuing Operation Net Minority Interest
-19,645
-17,338
-21,507
-18,667
-10,532
Normalized EBITDA
-18,456
-16,177
-20,646
-18,190
-10,179
12/31/2021 - 5/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade